Allison awarded a fellowship from Debbie's Dream Foundation

David Allison, PhD, a postdoctoral fellow in Greg Wang's lab, will use the funding to study the contribution of the polycomb repressive complex (PRC2) towards gastric cancer progression.

David Allison has been awarded a one-year $50,000 fellowship by Debbie's Dream Foundation, which is a 501(c)(3) non-profit organization dedicated to raising awareness about stomach cancer, advancing funding for research, and providing education and support internationally to patients, families, and caregivers.

Dr. Allison will be studying the contribution of the polycomb repressive complex (PRC2) towards gastric cancer progression. He is a postdoctoral fellow in the Greg Wang Lab. The lab studies how dysregulation of epigenetic factors drives inappropriate gene expression and subsequent tumorigenesis. Specifically, his project establishes the PRC2 complex as a viable target for chemotherapeutic inhibition in the treatment of gastric malignancies. 

Fellowship news release:  http://www.aacr.org/home/public--media/aacr-in-the-news.aspx?d=3257